Posts in category Exclusively Published


Trade Like Dmitry Balyasny: Valeant Pharmaceuticals Intl Inc (VRX), Apple Inc. (AAPL), Advanced Micro Devices, Inc. (AMD)

Balyasny Asset Management’s Dmitry Balyasny has adjusted some crucial stocks in the fund’s portfolio in …

Read more

Insider Trading News: Valeant Pharmaceuticals Intl Inc (VRX), American Airlines Group Inc (AAL), Starbucks Corporation (SBUX)

Recently, various executives have taken part in insider trading activity in Valeant Pharmaceuticals Intl Inc (NYSE:VRX), American Airlines …

Read more

Oppenheimer Raises Price Target For Baidu Inc (ADR) (BIDU) Following 4Q:15 Results

In a research report released today, Oppenheimer analyst Jason Helfstein reiterated an Outperform rating on …

Read more

What To Expect Ahead Of Valeant Pharmaceuticals Intl Inc’s (VRX) Fourth Quarter Earnings: Cannacord

Canaccord analyst Neil Maruoka weighed in today with his views on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), as …

Read more

Brean Capital Slashes Price Target on Keryx Biopharmaceuticals (KERX) on Back of Disappointing Revenue Guidance

In a research report issued Thursday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating …

Read more

J.P. Morgan Heads to Sidelines on PTC Therapeutics, Inc. (PTCT) Amid FDA Setback; Slashes Price Target

Tuesday turned out to be a nightmare for shareholders of PTC Therapeutics, Inc. (NASDAQ:PTCT) as the …

Read more

Cowen Sees FDA Approval For Heron Therapeutics Inc’s (HRTX) CINV Drug

Cowen’s healthcare analyst Boris Peaker weighed in today on biotech firm Heron Therapeutics Inc (NASDAQ:HRTX), following the …

Read more

Canaccord Weighs In On AEterna Zentaris Inc. (USA) (AEZS) Following Co-Promotion Agreement For APIFINY In The US

Canaccord’s healthcare analyst Neil Maruoka weighed in on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the …

Read more

Canaccord Remains Bearish on Seadrill Ltd (SDRL) Following 3Q:15 Results; Here’s Why

In a research report issued Wednesday, Canaccord analyst Alex Brooks reiterated a Sell rating on shares …

Read more

BTIG Cautious on Pfizer Inc.’s (PFE) and Allergan PLC’s (AGN) “Mega Inversion” Deal

BTIG analyst Tim Chiang weighed in today with a cautious stance on the “Mega Inversion” deal between Pfizer …

Read more